Amphotericin B enhances the synthesis and release of the immunosuppressive agent gliotoxin from the pulmonary pathogen Aspergillus fumigatus

Journal of Medical Microbiology

Volumn 53, Issue 8, 2004, Pages 719-725

  Reeves, Emer P ^a   Murphy, Thomas ^a   Daly, Paul ^a   Kavanagh, Kevin ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMPHOTERICIN B; DIMETHYL SULFOXIDE; GLIOTOXIN; IMMUNOSUPPRESSIVE AGENT; PROTEIN; ANTIFUNGAL AGENT; FUNGAL PROTEIN;

ARTICLE; ASPERGILLUS FUMIGATUS; CELL MEMBRANE PERMEABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DRUG SYNTHESIS; FUNGUS HYPHAE; LUNG PARENCHYMA; METABOLISM; MYCELIUM; NONHUMAN; PRIORITY JOURNAL; CHEMISTRY; CYTOPLASM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING;

AMINO ACIDS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CELL MEMBRANE PERMEABILITY; CULTURE MEDIA; CYTOPLASM; DIMETHYL SULFOXIDE; FUNGAL PROTEINS; GLIOTOXIN; MYCELIUM;

EID: 4344618346     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45626-0     Document Type: Article

References (30)

1. Abu-Salah, K. M. (1996). Amphotericin B: an update. Br J Biomed Sci 53, 122-133.
2. Amitani, R., Murayama, T., Nawada, R., Lee, W. J., Niimi, A., Suzuki, K., Tanaka, E. & Kuze, F. (1995a). Aspergillus culture filtrates and sputum sols from patients with pulmonary aspergillosis cause damage to human respiratory ciliated epithelium in vitro. Eur Respir J 8, 1681-1687.
3. Amitani, R., Taylor, G., Elezis, E.-N., Llewellyn-Jones, C., Mitchell, J., Kuze, F., Cole, P. J. & Wilson, R. (1995b). Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 63, 3266-3272.
4. Bertout, S., Badoc, C., Mallie, M., Giamimis, J. & Bastide, J. M. (2002). Spore diffusate isolated from some strains of Aspergillus fumigatus inhibits phagocytosis by murine alveolar macrophages. FEMS Immunol Med Microbiol 33, 101-106.
5. Braithwaite, A. W., Eichner, R. D., Waring, P. & Mullbacher, A. (1987). The immunomodulating agent gliotoxin causes genomic DNA fragmentation. Mol Immunol 24, 47-55.
6. Canuto, M. M. & Rodero, F. G. (2002). Antifungal drug resistance to azoles and polyenes. Lancet (Infect Dis) 2, 550-563.
7. Cohen, B. E. (1998). Amphotericin B toxicity and lethality: a tale of two channels. Int J Pharm 162, 95-106.
8. Daly, P. & Kavanagh, K. (2001). Pulmonary aspergillosis: clinical presentation, diagnosis and therapy. Br J Biomed Sci 58, 197-205.
9. Denning, D. W. (1996a). Aspergillosis: diagnosis and treatment. Int J Antimicrob Agents 6, 161-168.
10. Denning, D. W. (1996b). Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 23, 608-615.
11. Denning, D. W. (1998). Invasive aspergillosis. Clin Infect Dis 26, 781-805.
12. Eichner, R. D., Al Salami, M., Wood, P. R. & Mullbacher, A. (1986). The effect of gliotoxin upon macrophage function. Int J Immunopharmacol 8, 789-797.
13. Ellis, D. (2002). Amphotericin B: spectrum and resistance. J Antimicrob Chemother 49, 7-10.
14. Fraser, R. S. (1993). Pulmonary aspergillosis: pathologic and pathogenetic features. Pathol Annu 28, 231-277.
15. Ghosh, A. & Ghosh, J. J. (1963). Release of intracellular constituents of Candida albicans in presence of polyene antibiotics. Ann Biochem Exp Med 23, 611-626.
16. Gordeliy, V. I., Kiselev, M. A., Lesieur, P., Pole, A. V. & Teixeira, J. (1998). Lipid membrane structure and interactions in dimethyl sulfoxide/water mixtures. Biophys J 75, 2343-2351.
17. Hartsel, S. & Bolard, J. (1996). Amphotericin B: new life for an old drug. Trends Pharmacol Sci 17, 445-449.
18. Hogan, L. H., Klein, B. S. & Levitz, S. M. (1996). Virulence factors of medically important fungi. Clin Microbiol Rev 9, 469-488.
19. Liao, R. S., Rennie, R. P. & Talbot, J. A. (1999). Assessment of the effect of amphotericin B on the vitality of Candida albicans. Antimicrob Agents Chemother 43, 1034-1041.
20. Piva, T. J. (1994). Gliotoxin induces apoptosis in mouse L929 fibroblast cells. Biochem Mol Biol Int 33, 411-419.
21. Richard, J. L. & DeBey, M. C. (1995). Production of gliotoxin during pathogenic state in turkey poults by Aspergillus fumigatus, Fresenius. Mycopathologia 129, 111-115.
22. Richard, J. L., Dvorak, T. J. & Ross, P. F. (1996). Natural occurrence of gliotoxin in turkeys infected with Aspergillus fumigatus, Fresenius. Mycopathologia 134, 167-170.
23. Shah, D. T., Glover, D. D. & Larsen, B. (1995). In situ mycotoxin production by Candida albicans in women with vaginitis. Gynecol Obstet Invest 39, 67-69.
24. Sutton, P., Newcombe, N. R., Waring, P. & Mullbacher, A. (1994). In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun 62, 1192-1198.
25. Sutton, P., Moreland, A., Hutchinson, I. V. & Mullbacher, A. (1995). Investigation of the potential use of immunosuppressive agent gliotoxin in organ transplantation. Transplantation 60, 900-902.
26. Sutton, P., Waring, P. & Mullbacher, A. (1996). Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin. Immunol Cell Biol 74, 318-322.
27. Venegas, B., Gonzalez-Damian, J., Celis, H. & Ortega-Blake, I. (2003). Amphotericin B channels in the bacterial membrane: role of sterol and temperature. Biophys J 85, 2323-2332.
28. Waring, P. (1990). DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels. J Biol Chem 265, 14476-14480.
29. Waring, P. & Beaver, J. (1996). Gliotoxin and related epipolythiodiox-opiperazines. Gen Pharmacol 27, 1311-1316.
30. Yu, Z. W. & Quinn, P. J. (1998). Solvation effects of dimethyl sulphoxide on the structure of phospholipid bilayers. Biophys Chem 70, 35-39.